The American College of Cardiology has issued Concise Clinical Guidance (CCG) recommending vaccines to protect adults pinch bosom illness against respiratory illness, including influenza, COVID-19 and RSV, and different diseases wherever vaccination is shown to connection cardiovascular protective benefits. The guidance besides provides elaborate grounds for each vaccine proposal and answers to often asked questions to guideline conversations betwixt clinicians and patients.
Vaccination against communicable respiratory diseases and different superior diseases is captious for group pinch bosom disease, but barriers beryllium to ensuring group are knowledgeable connected which vaccines to get, really often to get them and why they are important. With this document, we want to promote clinicians to person these conversations and thief their patients negociate vaccination arsenic portion of a modular prevention and curen plan."
Paul Heidenreich, MD, FACC, chair of nan CCG penning committee
People pinch bosom illness person a higher consequence of infection erstwhile exposed to a respiratory microorganism and a higher consequence of adverse outcomes, including hospitalization and death. Studies person shown that vaccines are highly effective successful reducing these risks; however, a caller study showed only 30% of superior attraction physicians are assessing their patients' vaccination position astatine session visits.
The ACC issued this CCG to consolidate vaccine-specific recommendations made by ACC/American Heart Association guidelines and nan Centers for Disease Control and Prevention. The guidance chiefly focuses connected respiratory vaccines but besides offers guidance based connected emerging grounds that different vaccines-such arsenic nan herpes zoster (shingles) vaccine-may connection cardiovascular protective benefits.
Vaccine circumstantial guidance includes:
- Influenza – An yearly flu vaccine is recommended for each adults to trim cardiovascular morbidity, cardiovascular mortality and all-cause death. Nasal versions of nan vaccine are not recommended successful patients complete 50.
- Pneumococcal – recommended for adults 19 aliases older pinch bosom illness to get this one-time vaccine to protect against pneumonia, bacteremia and meningitis and related consequence of hospitalization and death. Following CDC/Advisory Committee connected Immunization Practices recommendation, nan guidance advises a azygous dose of PCV20 aliases PCV21, aliases PCV15 followed by PPSV23 depending connected anterior vaccination history.
- COVID-19 – For nan 2024–25 season, each adults pinch bosom illness were recommended to person nan seasonal COVID-19 vaccine. Future vaccination wave whitethorn change, but it is apt vaccination will stay beneficial for those pinch bosom disease. Benefits see reduced consequence of infection, terrible infection, death, bosom attack, COVID-19 induced pericarditis/myocarditis, COVID-19 induced changeable and atrial fibrillation, and agelong COVID symptoms.
- RSV – recommended for adults 75 aliases older and for adults aged 50–74 pinch bosom illness to protect against little respiratory illness that tin consequence successful hospitalization and death. Current guidance recommends a azygous dose, alternatively than yearly vaccination.
- Shingles – recommended for adults 50 aliases older to person 2 doses to protect against accrued consequence of changeable and bosom onslaught erstwhile infected. People pinch bosom illness are astatine an accrued consequence of shingles infection.
The archive outlines strategies to amended vaccination rates, reside hesitancy and flooded barriers to access, noting that clinician-patient discussions astir vaccination during cardiology visits tin beryllium an important opportunity to merge vaccination into a cardiovascular attraction plan.
"2025 Concise Clinical Guidance: An ACC Expert Consensus Statement connected Adult Immunizations arsenic Part of Cardiovascular Care" will people successful JACC, nan flagship diary of nan ACC, connected Aug. 26, 2025.